Remove 2016 Remove Competition Remove Prescription Remove Sales
article thumbnail

Prescription drug prices are out of cotrol

World of DTC Marketing

This includes about one in five who report that they have not filled a prescription or took an over-the counter drug instead, and about one in ten who say they have cut pills in half or skipped a dose. The public sees profits made by pharmaceutical companies as the largest factor contributing to the price of prescription drugs.

article thumbnail

Shareholders versus patients: Who is more important?

World of DTC Marketing

SKIMMERS SUMMARY: There is one and only one social responsibility of business–to use its resources and engage in activities designed to increase its profits so long as it stays within the rules of the game, which is to say, engages in open and free competition without deception or fraud. Milton Friedman.

Patients 156
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nine for 2023, part one: a reflection on inflection

pharmaphorum

The innovative prescription medicine industry faces a trifecta of challenges. Compared to major primary care markets of the late 1990s/early 2000s, specialty care markets see more and earlier competitive launches, and the market share achieved by each launch after is progressively reduced. Pharma boxed in? It is not alone.

article thumbnail

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

pharmaphorum

The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth. Non-COVID prescription medicines didn’t stop launching during the pandemic — approvals by both the FDA and the EMA were, in fact historically high in both 2020 and 2021. The scope of the problem.

Doctors 57